Lateral Flow Assay Market 2023 | Size, Demand, Share, Growth And Forecast 2028

Lateral Flow Assay Market 2023 | Size, Demand, Share, Growth And Forecast 2028

IMARC Group, a leading market research company, has released a report titled “Lateral Flow Assay Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028“. According to the report, The global lateral flow assay market size reached US$ 9.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 13.3 Billion by 2028, exhibiting a growth rate (CAGR) of 5% during 2023-2028.

The Lateral Flow Assay (LFA) is a widely employed diagnostic technique for quick and on-the-spot testing. This straightforward and user-friendly method determines the presence or absence of a specific target analyte, such as a virus or bacteria, in each sample. It utilizes a paper-based strip coated with biomolecules, including antibodies or antigens, which can capture the target analyte. It plays a crucial role in examining various biological samples like saliva, urine, sweat, serum, plasma, blood, and other fluids. It is used in hospitals and clinical laboratories to detect specific agents, antibodies, and gene amplification, both qualitatively and quantitatively. In addition, it helps develop cost-effective, user-friendly, swift, and portable detection devices used in biomedicine, agriculture, food, and environmental sciences. The LFA offers numerous advantages, such as it provides rapid results and do not require specialized equipment or expertise for execution, over traditional diagnostic tests. As a result, the LFA finds extensive application in the detection of infectious diseases, pregnancy testing, and drug screening across the globe.

Request For Sample Report (Exclusive Offer on this report): https://www.imarcgroup.com/lateral-flow-assay-market/requestsample

Lateral Flow Assay Market Trends and Drivers:

The global lateral flow assay market is primarily driven by the rising prevalence of infectious diseases among populations and the growing demand for quick and dependable diagnostic tests to swiftly detect and treat diseases. Moreover, the shifting inclination toward point-of-care testing, aiming to enhance patient outcomes by delivering rapid and accurate test results, enabling early disease diagnosis and care, is positively influencing the market growth. Apart from this, continuous technological advancements and the emergence of multiplex LFAs, capable of detecting multiple target analytes in a single test using a single sample, are propelling market growth. Additionally, the surging adoption of gold nanosphere-based surface-enhanced Raman scattering (SERS) labels in LFA measurements, due to their strong anti-interference and high sensitivity capabilities, has catalyzed the market growth. Besides this, the implementation of extensive awareness programs to improve infection spread, diagnosis, and prevention is another major growth-inducing factor. In addition, the escalating demand for alternative methods of transporting patient samples to laboratories amid the COVID-19 pandemic due to the limited availability of extensive laboratory facilities and trained healthcare personnel capable of conducting polymerase chain reaction (PCR) tests has accelerated the product adoption rate. Furthermore, key players introducing innovative signal enhancement techniques and enhancing quantification systems for simultaneous detection are contributing to the market growth. Other factors, including extensive research and development (R&D) activities by key players, significant improvements in the healthcare sector, and rapid urbanization, are also anticipated to drive the market further.

Report Segmentation:

The report has segmented the market into the following categories:

Breakup by Technique:

  • Sandwich Assays
  • Competitive Assays
  • Multiplex Detection Assays

Breakup by Product:

  • Kits and Reagents
  • Lateral Flow Readers
    • Digital/Mobile Readers
    • Benchtop Readers

Breakup by Application:

  • Clinical Testing
    • Infectious Disease Testing
    • Cardiac Marker Testing
    • Pregnancy and Fertility Testing
    • Cholesterol Testing/Lipid Profile
    • Drug Abuse Testing
    • Others
  • Veterinary Diagnostics
  • Food Safety and Environment Testing
  • Drug Development and Quality Testing

Breakup by End User:

  • Hospitals and Clinics
  • Diagnostic Laboratories
  • Home Care
  • Pharmaceutical and Biotechnology Companies
  • Others

Market Breakup by Region:

  • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa

Competitive Landscape with Key Player:

  • Abbott Laboratories
  • Becton Dickinson and Company
  • Biomérieux SA
  • Bio-Rad Laboratories Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • Hologic Inc.
  • Merck KGAA
  • Perkinelmer Inc
  • Qiagen N.V.
  • Quidel Corporation
  • Siemens Healthineers AG (Siemens AG)
  • Thermo Fisher Scientific Inc.

Explore full report with table of contents: https://www.imarcgroup.com/lateral-flow-assay-market

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact US

IMARC Group

Email: [email protected]

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Address: 134 N 4th St. Brooklyn, NY 11249, USA

Follow us on Twitter: @imarcglobal